التفاصيل البيبلوغرافية
| العنوان: |
Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agents. |
| المؤلفون: |
Shiga, Hisashi, Takahashi, Takahiro, Shiraki, Manabu, Kojima, Yasuhiro, Tsuji, Tsuyotoshi, Takagi, Sho, Hiramoto, Keiichiro, Yokoyama, Naonobu, Sugimura, Mikako, Iwabuchi, Masahiro, Endo, Katsuya, Onodera, Motoyuki, Sato, Yuichirou, Shimodaira, Yosuke, Nomura, Eiki, Kikuchi, Tatsuya, Chiba, Hirofumi, Oomori, Shinya, Kudo, Hisaaki, Kumada, Kazuki |
| المصدر: |
Scandinavian Journal of Gastroenterology; Apr2023, Vol. 58 Issue 4, p360-367, 8p |
| مصطلحات موضوعية: |
INFLAMMATORY bowel diseases, CROHN'S disease, IMMUNOSUPPRESSIVE agents, SEROCONVERSION, ENZYME-linked immunosorbent assay |
| مستخلص: |
Although live-attenuated vaccines are contraindicated under immunosuppression, the immune status of patients with inflammatory bowel disease (IBD) has not been fully assessed prior to immunosuppressive therapy. To investigate antiviral serostatus against viruses requiring live vaccines for prevention in IBD patients undergoing immunosuppressive therapy. This multicenter study included IBD patients who were aged <40 years and were treated with thiopurine monotherapy, molecular-targeted monotherapy, or combination therapy. Gender- and age-matched healthy subjects (HS) living in the same areas were included as control group. Antibody titers against measles, rubella, mumps, and varicella were measured by enzyme-linked immunosorbent assays. A total of 437 IBD patients (163 ulcerative colitis [UC] and 274 Crohn's disease [CD]) and 225 HS were included in the final analysis. Compared with HS, IBD patients had lower seropositivity rates for measles (IBD vs. HS = 83.91% vs. 85.33%), rubella (77.55% vs. 84.89%), mumps (37.50% vs. 37.78%), and varicella (91.26% vs. 96.44%). Gender- and age-adjusted seropositivity rates were lower in UC patients than in both CD patients and HS for measles (UC, CD, and HS = 81.60%, 85.29%, and 85.33%), rubella (76.40%, 78.23%, and 84.89%), mumps (27.16%, 43.70%, and 37.78%), and varicella (90.80%, 91.54%, and 96.44%); the difference was significant for all viruses except measles. Divided by the degree of immunosuppression, there were no significant differences in seropositivity rates among IBD patients. IBD patients, especially those with UC, exhibit reduced seropositivity rates and may benefit from screening prior to the initiation of immunosuppressive therapy. [ABSTRACT FROM AUTHOR] |
|
Copyright of Scandinavian Journal of Gastroenterology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
PDF full text from Publisher